145 related articles for article (PubMed ID: 27227839)
1. Polyamine derivatives: a revival of an old neglected scaffold to fight resistant Gram-negative bacteria?
Blanchet M; Borselli D; Brunel JM
Future Med Chem; 2016 Jun; 8(9):963-73. PubMed ID: 27227839
[TBL] [Abstract][Full Text] [Related]
2. Motuporamine Derivatives as Antimicrobial Agents and Antibiotic Enhancers against Resistant Gram-Negative Bacteria.
Borselli D; Blanchet M; Bolla JM; Muth A; Skruber K; Phanstiel O; Brunel JM
Chembiochem; 2017 Feb; 18(3):276-283. PubMed ID: 28098416
[TBL] [Abstract][Full Text] [Related]
3. 6-Bromoindolglyoxylamido derivatives as antimicrobial agents and antibiotic enhancers.
Li SA; Cadelis MM; Sue K; Blanchet M; Vidal N; Brunel JM; Bourguet-Kondracki ML; Copp BR
Bioorg Med Chem; 2019 May; 27(10):2090-2099. PubMed ID: 30975502
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and antibacterial activities of neomycin-lipid conjugates: polycationic lipids with potent gram-positive activity.
Bera S; Zhanel GG; Schweizer F
J Med Chem; 2008 Oct; 51(19):6160-4. PubMed ID: 18778047
[TBL] [Abstract][Full Text] [Related]
5. Small-molecule suppression of β-lactam resistance in multidrug-resistant gram-negative pathogens.
Brackett CM; Melander RJ; An IH; Krishnamurthy A; Thompson RJ; Cavanagh J; Melander C
J Med Chem; 2014 Sep; 57(17):7450-8. PubMed ID: 25137478
[TBL] [Abstract][Full Text] [Related]
6. Multidrug-resistant Gram-negative bacterial infections: the emerging threat and potential novel treatment options.
Vergidis PI; Falagas ME
Curr Opin Investig Drugs; 2008 Feb; 9(2):176-83. PubMed ID: 18246520
[TBL] [Abstract][Full Text] [Related]
7. Fosfomycin.
Falagas ME; Vouloumanou EK; Samonis G; Vardakas KZ
Clin Microbiol Rev; 2016 Apr; 29(2):321-47. PubMed ID: 26960938
[TBL] [Abstract][Full Text] [Related]
8. Synergistic activity profile of an antimicrobial peptide against multidrug-resistant and extensively drug-resistant strains of Gram-negative bacterial pathogens.
Pollini S; Brunetti J; Sennati S; Rossolini GM; Bracci L; Pini A; Falciani C
J Pept Sci; 2017 Apr; 23(4):329-333. PubMed ID: 28176481
[TBL] [Abstract][Full Text] [Related]
9. Combination therapy with intravenous colistin for management of infections due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis.
Kasiakou SK; Michalopoulos A; Soteriades ES; Samonis G; Sermaides GJ; Falagas ME
Antimicrob Agents Chemother; 2005 Aug; 49(8):3136-46. PubMed ID: 16048915
[TBL] [Abstract][Full Text] [Related]
10. Predominance of Gram-negative bacilli and increasing antimicrobial resistance in nosocomial bloodstream infections at a university hospital in southern Taiwan, 1996-2003.
Wu CJ; Lee HC; Lee NY; Shih HI; Ko NY; Wang LR; Ko WC
J Microbiol Immunol Infect; 2006 Apr; 39(2):135-43. PubMed ID: 16604246
[TBL] [Abstract][Full Text] [Related]
11. Serious antimicrobial resistance status of pathogens causing hospital-acquired lower respiratory tract infections in North China.
Wang Y; Zhang R; Li W; Feng Y; Leng T
J Int Med Res; 2009; 37(3):899-907. PubMed ID: 19589276
[TBL] [Abstract][Full Text] [Related]
12. Repurposing primaquine as a polyamine conjugate to become an antibiotic adjuvant.
Pearce AN; Chen D; Edmeades LR; Cadelis MM; Troudi A; Brunel JM; Bourguet-Kondracki ML; Copp BR
Bioorg Med Chem; 2021 May; 38():116110. PubMed ID: 33831695
[TBL] [Abstract][Full Text] [Related]
13. Enhancing antibiotic activity to combat resistant Gram-negative bacteria: what's next?
Bolla JM; Brunel JM
Future Med Chem; 2014; 6(17):1849-51. PubMed ID: 25495978
[No Abstract] [Full Text] [Related]
14. Tigecycline: first of a new class of antimicrobial agents.
Rose WE; Rybak MJ
Pharmacotherapy; 2006 Aug; 26(8):1099-110. PubMed ID: 16863487
[TBL] [Abstract][Full Text] [Related]
15. Overcoming multidrug resistance in gram-negative bacteria.
Poole K
Curr Opin Investig Drugs; 2003 Feb; 4(2):128-39. PubMed ID: 12669372
[TBL] [Abstract][Full Text] [Related]
16. [Emergence pathogens infections in ENT Department of Children's hospital in 2005-2008].
Zielnik-Jurkiewicz B; Rakowska-Szkudlarek M
Otolaryngol Pol; 2009; 63(6):513-9. PubMed ID: 20198987
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial Resistance in the Intensive Care Unit: A Focus on Gram-Negative Bacterial Infections.
MacVane SH
J Intensive Care Med; 2017 Jan; 32(1):25-37. PubMed ID: 26772199
[TBL] [Abstract][Full Text] [Related]
18. Development of new polymyxin derivatives for multi-drug resistant Gram-negative infections.
Brown P; Dawson MJ
J Antibiot (Tokyo); 2017 Apr; 70(4):386-394. PubMed ID: 28074057
[TBL] [Abstract][Full Text] [Related]
19. Polyamine effects on antibiotic susceptibility in bacteria.
Kwon DH; Lu CD
Antimicrob Agents Chemother; 2007 Jun; 51(6):2070-7. PubMed ID: 17438056
[TBL] [Abstract][Full Text] [Related]
20. Clinical and microbiologic review of culture-proven endophthalmitis caused by multidrug-resistant bacteria in patients seen at a tertiary eye care center in southern India.
Pathengay A; Moreker MR; Puthussery R; Ambatipudi S; Jalali S; Majji AB; Mathai A; Husssain N; Dave V; Sharma S; Das T
Retina; 2011 Oct; 31(9):1806-11. PubMed ID: 21478803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
